Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Continuous Infusion Versus Intermittent Bolus Doses of Indomethacin for Patent Ductus Arteriosus Closure in Symptomatic Preterm Infants." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/repview. Accessed 02 May 2024.
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/repview. Accessed May 2, 2024.
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/repview
Continuous Infusion Versus Intermittent Bolus Doses of Indomethacin for Patent Ductus Arteriosus Closure in Symptomatic Preterm Infants [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants
ID - 436862
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -